ESMO Colloquium supported by Eli Lilly and Company: Precision Medicine Implementation in the Clinic: RET as a potential target in cancer treatment
Conclusion: Is RET targeting ready for an agnostic use?
Date
22 Sep 2020Session
ESMO Colloquium supported by Eli Lilly and Company: Precision Medicine Implementation in the Clinic: RET as a potential target in cancer treatmentPresenters
Alexander DrilonAuthors
A. DrilonAuthor affiliations
- Memorial Sloan Kettering Evelyn H. Lauder Breast Center, 10065 - New York/US
Resources
Resources from the same session
Introduction
Presenter: Giuseppe Curigliano
Session: ESMO Colloquium supported by Eli Lilly and Company: Precision Medicine Implementation in the Clinic: RET as a potential target in cancer treatment
Resources:
Slides
Webcast
Introduction to RET mutations and fusions and their incidence for potential use as target in cancer treatment
Presenter: Alexander Drilon
Session: ESMO Colloquium supported by Eli Lilly and Company: Precision Medicine Implementation in the Clinic: RET as a potential target in cancer treatment
Resources:
Slides
Webcast
RET fusion TKI: Present results and recent developments in Lung cancer
Presenter: David Planchard
Session: ESMO Colloquium supported by Eli Lilly and Company: Precision Medicine Implementation in the Clinic: RET as a potential target in cancer treatment
Resources:
Slides
Webcast
RET alterations in Thyroid carcinomas: Results and recent update
Presenter: Lori Wirth
Session: ESMO Colloquium supported by Eli Lilly and Company: Precision Medicine Implementation in the Clinic: RET as a potential target in cancer treatment
Resources:
Slides
Webcast
RET determination: Present recommendation of the ESMO Precision Medicine working group
Presenter: Giuseppe Curigliano
Session: ESMO Colloquium supported by Eli Lilly and Company: Precision Medicine Implementation in the Clinic: RET as a potential target in cancer treatment
Resources:
Slides
Webcast
Live Q&A
Presenter: Alexander Drilon
Session: ESMO Colloquium supported by Eli Lilly and Company: Precision Medicine Implementation in the Clinic: RET as a potential target in cancer treatment
Resources:
Webcast
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
-
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.